Found 5 matching trials
Study of the Booster Effect of DTaP-IPV-Hep B-PRP~T Combined Vaccine or Infanrix Hexa™ and Prevenar™ in Healthy Infants PHASE3 This is a follow-up of the primary series vaccination schedule in Study A3L...
Show More Location
Multiple Locations
Learn More & Join Trial
Comparison of a DTaP-IPV-HB-PRP~T Combined Vaccine to Infanrix™-Hexa, When Administered With Prevnar® in Thai Infants PHASE3 The purpose of the study is to provide immunogenicity and safety data of th...
Show More Location
Multiple Locations
Learn More & Join Trial
Antibody Persistence at Age 3.5 and 4.5 Years After Primary and Booster DTaP-IPV-Hep B-PRP~T or Infanrix Hexa Vaccination PHASE3 This is a follow-up of the primary series vaccination schedule in Study A3L...
Show More Location
Multiple Locations
Learn More & Join Trial
Anti-Hep B Antibodies at Age 12 to 18 Months After Hep B Vaccine at Birth and DTaP-IPV-Hep B-PRP-T Hexavalent Vaccine Concomitantly With Prevnar® at 2, 4 and 6 Months of Age NA Primary Objective:
To describe the persistence of Hep B antibodies (Ab) at...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of DTaP-IPV-Hep B-PRP-T Vaccine Given With Prevenar™ and Rotarix™ in Healthy Latin American Infants PHASE3 The purpose of this study is to generate immunogenicity and safety data of ...
Show More Location
Multiple Locations
Learn More & Join Trial